Parnax Lab Limited (PARNAXLAB) Financial History

Name: Parnax Lab Limited (PARNAXLAB) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Parnax Lab Limited (PARNAXLAB) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 12 employees. In the fiscal year ended 2026-03-31, PARNAXLAB reported ₹2.5B in revenue and ₹118M in net income.

Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic; herbal; and nutraceutical products.

Interactive charts & full statements →

PARNAXLAB Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹2.5B	₹1.9B	₹1.9B	₹1.7B
Gross Profit	₹678M	₹627M	₹554M	₹513M
Operating Income (EBIT)	₹235M	₹198M	₹167M	₹168M
Net Income	₹118M	₹115M	₹96M	₹86M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PARNAXLAB Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹568M	₹696M	₹629M	₹626M	₹534M
Gross Profit	₹245M	₹262M	₹256M	₹263M	₹234M
Operating Income (EBIT)	₹21M	₹28M	₹49M	₹60M	₹55M
Net Income	₹4M	₹22M	₹27M	₹36M	₹33M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PARNAXLAB Free Cash Flow History

PARNAXLAB Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹2.3B	₹1.9B	₹1.9B	₹1.5B	—
Total Liabilities	₹1.3B	₹1.1B	₹1.2B	₹828M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PARNAXLAB viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

CHLL · Chill Brands Group PLC — £1 million
BPLPHARMA · Bharat Parenterals Limited
JENBURPH · Jenburkt Pharmaceuticals Limited
KPL · Kwality Pharmaceuticals Limited
SUNLOC · Sunil Healthcare Limited
4502 · Takeda Pharmaceutical Company Limited — JPY 9.53 trillion
SUNPHARMA · Sun Pharmaceutical Industries Limited — ₹4.41 trillion
4507 · Shionogi & Co., Ltd. — JPY 2.51 trillion

← PARKHOTELS All “P” companies PARP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.